Lannett Company Inc (NYSE:LCI)

55.39
Delayed Data
As of May 22
 +0.66 / +1.21%
Today’s Change
33.51
Today|||52-Week Range
72.44
+29.17%
Year-to-Date

Today’s Trading

Previous close54.73
Today’s open54.75
Day’s range54.49 - 56.10
Volume701,914
Average volume (3 months)955,277
Market cap$2.0B
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+252.17%
Earnings growth (this year)+144.60%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+81.24%
P/E ratio14.7
Price/Sales5.27
Price/Book6.69

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...+0.05+0.36%
SAGESAGE Therapeutics In...+0.68+1.00%
THRXTheravance Inc+0.34+2.08%
INSYINSYS Therapeutics I...+2.08+3.63%
Data as of 4:00pm ET, 05/22/2015

Financials

Next reporting dateSeptember 8, 2015
EPS forecast (this quarter)$0.85
Annual revenue (last year)$273.8M
Annual profit (last year)$57.1M
Net profit margin20.86%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO, Director &
Head-Investor Relations
Arthur P. Bedrosian
President
Michael J. Bogda
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers